By Howard Wolinsky, The Active Surveillor
Irish researcher Antoinette Perry at University College Dublin is asking some provocative questions in a survey I heard about today at the webinar by Active Surveillance Patients International.
Why not pitch in? It’s focused on the early days of a diagnosis of prostate cancer. So tell Antoinette Perry that howard@TheActiveSurveillor.com wants to chat.
It’s called the IMPROVER (Involving Men with Prostate Cancer in Engaged Research, funded by the Irish Research Council, UCD in conjunction with the Irish Cancer Society and Breakthrough Cancer Research.
Here you go: https://healthandagriscience.fra1.qualtrics.com/jfe/form/SV_026zL2WGAcuZMbQ
I participated in the survey on 2/26/2022. I found the questions to be rather comprehensive and was especially appreciative of the fact that there was adequate room for clarification and comments.